CGMs offer a real-time, continuous stream of glucose data, empowering users to identify trends and make informed adjustments to their diabetes management. Whether it's adapting to a new workout ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...

1 The new Dexcom GenAI platform will analyze individual ... is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) System has now been added to the Alberta Drug Benefit ...

DexCom Inc. DXCM is off to a strong start in 2025, with its stock rallying 5.7% following the release of its preliminary ...

Johnson is confident in Dexcom’s ability to achieve substantial revenue and earnings growth, supporting a higher valuation multiple and justifying the new price target of $104. In another report ...

DexCom demonstrated strong product demand in third-quarter 2024, highlighted by record new patient starts in its core markets. The flagship G7 and DexCom ONE+ platforms continued to drive adoption ...